Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Lung Cancer
- Vol. 5 (1) , 33-38
- https://doi.org/10.3816/clc.2003.n.019
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinomaCancer, 2002
- Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized TrialJNCI Journal of the National Cancer Institute, 2002
- Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594Cancer, 2001
- Gemcitabine and Taxane Combinations in Non–Small-Cell Lung CancerClinical Lung Cancer, 2000
- Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinomaCancer, 2000
- Phase I/II Study of Gemcitabine Plus Vinorelbine as First-Line Chemotherapy of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.Journal of Clinical Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958